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Southern Gardens is a wholly owned subsidiary of the US Sugar Corporation, with three 
orange groves located in southern Florida, near Lake Okeechobee, where we have a 0-
million-box capacity processing operation (Figures  and ). In a given year, we squeeze 
0% to 5% of all the oranges grown in Florida: 5,000 oranges a minute producing 
600,000 gallons a day. We store the juice in million-gallon tanks of which we have 56 
that we turn twice a year.
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Figure . Corporate assets of the US Sugar Corporation.
Citrus Greening (HLB)
Citrus greening—an insect-vectored bacterial disease, also known as huanglongbing 
(HLB)—was first detected in Florida in 005 on the heels of the citrus-canker eradica-
tion program, which elicited a widespread aversion to tree removal. After a 009 study, 
the National Academy of Sciences identified citrus greening as the most serious disease 
challenge they had ever reviewed (NRC, 00).
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Figure 3 shows the symptoms: yellow shoots, mottled leaves and dead trees. Mineral 
and nutritional deficiencies, and so on, can produce similar symptoms (Figure 4), which 
creates a problem.
Figure . Southern Gardens citrus-processing plant.
Figure 3. Gross symptoms of citrus-greening disease.
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The fruit is misshapen, normally smaller—operative word “normally”—and more and 
more mature fruit are showing infection (Figure 5).
Figure 6 illustrates the challenge of finding early symptoms. The insect carrying the 
pathogen—Liberibacter spp.—is as prevalent in Florida as the mosquito. When it feeds 
on an uninfected tree, it can be up to two years before the tree has symptoms.
In October of 005, we owned one of two commercial groves in which the disease was 
confirmed. Although we knew little of the disease, we had to be as proactive as possible. 
By January of 006, we were in Brazil where the disease had been diagnosed 8 months 
previously.
The state did a sampling to identify where the disease was in Florida. Figure 7 shows 
the progression.
Today, every citrus-producing county in Florida is infected. Figure 8 illustrates how 
rapidly it has spread through one of our groves; each block is 0 acres, and each spot is 
a GPS coordinate of a tree that was identified as infected and removed. To date, we have 
lost 30% of our acreage. We are the largest grower and processor of oranges in the state 
that is vertically integrated. We have identified in excess of 700,000 trees that are infected 
by this disease. Figure 9 shows the level of infection in Florida through 0. The data 
apply through 0 because, basically, the industry has quit tracking the progression of 
the disease. We can say, with reasonable certainty, that the infection rate is 00% in the 
Florida citrus industry; not every tree is infected, but 00% of the groves are infected.
Figure 4. Nutritional/mineral-deficiency symptoms.
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Best Practice
This disease has been in the citrus industry for years, in the Far East and elsewhere. The 
program that everybody started to follow was to inspect groves frequently—four times 
per year—aggressive roguing of infected trees, and full-time scouting for the Asian citrus 
Figure 6. Symptoms in the grove.
Figure 5. Fruit symptoms of citrus-greening disease.
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Figure 7. Spread of citrus greening, October 005, April 006, 
January 007, to June 007.
psyllid, Diaphorina citri, the vector. The industry is working hard to control the psyllid 
with aggressive applications of insecticides; however, we have learned that tolerance for 
the insect is less than zero. You have to assume it’s there. If you do nothing until you find 
it, then it is too late. Our growing costs have risen by over 40%, whereas our juice prices 
haven’t gone up by 40%. 
Challenges
Should different strategies be chosen in high-inoculum-load areas in comparison with 
low-inoculum-density areas? Such decisions have to be made “on the fly” and on a large 
scale. Relevant questions are: 
How long will a grove remain economically productive after the disease is detected?
Will replanted groves be disease free? If not, is there a time horizon or will the 
disease be there forever?
At which point should nutritional approaches be tried?
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Figure 8. How rapidly does citrus greening spread? Top, Oct. 005–Mar. 006; 
Middle, Oct. 006–Mar. 007; Bottom, Aug. 007–Oct. 007.
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Nutritional Approaches
Nutritional approaches have been adopted on the basis of anecdotal evidence. There are 
many such programs, most of which are combinations of foliar nutritional applications, 
phosphorous acid, and compounds that are thought to be elicitors of systemic acquired 
resistance.1 The goal is to maintain the productivity of existing trees. After spraying, the 
leaves absorb the nutrients and often look more healthy with less dieback. However, where 
these approaches have been tried in the past—in China and South Africa—they have not 
been successful over the long term.
Nutritional approaches cost more than pre-HLB growing costs, but less than psyllid 
control and roguing. On the other hand, the increased costs involved in nutritional 
approaches may be offset by circumventing scouting for psyllids and tree removal. But, 
whether using nutritional approaches or not, most growers are still attempting to control 
psyllids.
A major concern is that these alternative approaches are “forever” in that they involve 
acceptance of 00% infection, begging the questions of whether replanted young trees 
will grow and produce under high inoculum load and of how long the time horizon is 
until recovery is achieved. If psyllid control/roguing is chosen, the nutritional approach 
can also be employed later, but not the other way around.
Where Are We?
There are 8,000 citrus growers in Florida. Roughly 50% of the acreage is controlled by 
about 00 growers. A lot of the production is by small-area growers. There is consensus 
that the current losses result from HLB infection—with contributions from environmental 
stresses—and that the losses will continue to worsen. Initial replanting efforts have resulted 
in high levels of infection within 5 years, with no gain from nutritional approaches. Many 
groves—even those on nutritional programs—are beginning to decline.
Figure 9. Estimated percent of trees infected statewide.
1Analogous to the innate immune system in animals.
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Some 5% of the Florida crop was on the ground in June 03. If that’s a trend, what 
losses will occur in 04? Initial replanting efforts have resulted in high levels of infection 
in less than five years. In a newly planted 40-acre plot, we found 6% infection within 
8 months. On the other hand, that was before we realized that the tolerance for the 
psyllid had to be less than zero.
The solution to this disease, will involve four concurrent processes:
• Research
• Regulatory approval
• Horticultural/agricultural production
• Consumer approval
They have to be tackled at the same simultaneously, because we are not dealing with a corn 
plant, we are dealing with a tree. When we have the solution, we must be in a position to 
commercialize it immediately. Several relevant research programs are in progress:
• Disease-resistant plants
 — Texas A&M University
 — Integrated Plant Genetics, Inc.
• Insect-resistant plants
 — Cornell University
• Identification of synthetic resistance genes
 — AgroMed LLC
• Gene delivery
 — University of Florida
• Screening of potential genes.
 — USDA
The major focus of the research is at Texas A&M, on the development of a disease-resistant 
tree. A second similar project is in progress at IPG, based in Gainesville. Development 
of an insect-resistant tree may be assisted by synthesis of resistance genes for which sev-
eral delivery systems are being investigated. The research projects are at varying stages 
of completion; some are close to the identification of a commercial product. When we 
find the solution, it will be good for the industry as a whole; Southern Gardens will not 
monopolize it.
Gaining Deregulation
We are working closely with the federal agencies and have had multiple consultations 
since August 006 with USDA-APHIS, EPA and FDA. The solution will involve a plant-
incorporated protectant (PIP), therefore approval will be needed from all three agencies. 
With respect to the research here at Texas A&M, we will file for an experimental use 
permit (EUP) with the EPA as soon as possible.
An important question is, How do we challenge the solution? We have developed a rapid 
screening technique to identify resistant plants. In a greenhouse, plants grown under 
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optimal conditions are exposed to infected psyllids. Susceptibility to disease is identified 
within 8 months, significantly more quickly than can be achieved in the field. Plants that 
appear to be disease-resistant in the greenhouse are then evaluated in regulated field trials. 
This confirmation of resistance is the first step towards commercialization, then we have to 
work through regulatory approval of the technology, for which it is necessary to generate 
a significant amount of data to satisfy all of the requirements of USDA, EPA and FDA 
to prove that the product is safe. We are working through that process.
Figure 0 provides a summary of what we expect to have to do; these tests are projected 
to cost in excess of $3 million. Multiple other aspects come into play. For example, three 
law firms in Washington, DC, are working with us on this process. It is important to 
remember that we are not a multinational company. We’re a grower/processor, working 
with a network of people.
Figure 0. Summary of likely regulatory strictures imposed by
EPA, USDA and FDA.
Consumer Acceptance
After the regulatory process is completed, we must ensure that the consumer accepts the 
product. As of today, our research indicates that the HLB greening disease cannot be solved 
without genetically engineering the tree. If citrus-greening resistance were to be obtained 
with a human transgene or one from a crab or a pig, the orange juice would never make it 
to the supermarket shelf. Even though the two genes being transferred to citrus are from 
spinach, the disease-resistant product will have to be marketed carefully.
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Orange juice is in an interesting category. It’s akin to “motherhood,” so education will 
be fundamental to gaining consumer acceptance.
Benefits
The first and most important benefit is that the orange juice industry will survive in the 
United States. Although the Brazilians have the same disease, they have different regulations 
and larger growing areas, and they believe they can survive. Another major benefit will be 
the elimination of the insecticides now being used to control the insect that vectors the 
disease from infected to healthy trees. At this time, our groves are, essentially, insect-sterile 
because of the chemicals that we are applying to control the insect. When our genetic 
solution is put into practice, the impact on the environment will be huge.
The Future
Our task is daunting, but we have a good approach and our data show that we have 
good potential for resistance to citrus greening. On the other hand, at our present rate of 
progress, resistant trees may not be commercialized until 09, which is not acceptable. 
Figure . Typical fruit drop in 03.
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We must somehow speed up Mother Nature. If this year’s fruit drop (Figure ) is an 
indication of what’s coming—if we lose 5 percent every year—we could lose the orange-
juice industry. Texas and California are watching closely. California’s challenge is more 
pressing because they produce fresh fruit. In Florida, we blend juice, whereas California 
cannot offer an infected orange for eating. Also, virtually every backyard in the state of 
California includes citrus trees, which will add to the difficulty of disease control.
It’s a daunting task, but we’ve got an end goal in sight. Orange juice is not going to go 
away. Florida fruit is not going to go away. No other citrus-growing region can compare to 
Florida quality, day in and day out. But we have a significant job to do going forward.
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